CoreWeave CEO Reportedly Dismisses 'Circular Investment' Concerns, Says Companies Are Buying AI Infra Because Of Demand

Published : Oct 09, 2025, 06:20 PM IST
https://stocktwits.com/news-articles/markets/equity/coreweave-ceo-circular-investment-ai-infrastructure-demand/ch678PTR3K1

Synopsis

In an interview with CNBC, CEO Michael Intrator stated that it is not unusual to see partnerships between companies as they strive to serve consumers.

CoreWeave Inc. (CRWV) co-founder and CEO Michael Intrator reportedly dismissed growing concerns of “circular investment” in the artificial intelligence sector on Thursday.

In an interview with CNBC, Intrator stated that the world's largest technology companies are purchasing AI infrastructure from CoreWeave because they have a demand.

“It’s a fundamental infrastructure buildout that is taking place, and when you have such a massive scale investment in infrastructure, it is not unusual to see partnerships as people try to serve infrastructure to the consumers. It happens in other markets, it’s happening in this market,” he said in the interview.

CoreWeave shares were down nearly 1% in Thursday’s pre-market trade. Retail sentiment on Stocktwits around the company trended in the ‘bearish’ territory.

Get updates to this story developing directly on Stocktwits.<

For updates and corrections, email newsroom[at]stocktwits[dot]com.<

PREV

Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.

Recommended Stories

Brian Armstrong Warns Stablecoin Interest Ban Could Hand Advantage To China’s CBDC
Outlook Therapeutics Tanks Over 60% On Another FDA Blow – Here’s How Retail Is Reacting